Replacement | Medicines | 08/07/2011

In a letter dated July 7, 2011, the marketing authorization holder informed its customers that stability tests had revealed that the active ingredient content had been exceeded and that the batch concerned would therefore be replaced as a precautionary measure.

Name of the medicinal product Irinoliquid 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Marketing authorisation number(s) 1-29279
Marketing authorisation holder EBEWE Pharma Ges.m.b.H. Nfg.KG
Batch number(s) 95977814
Classification of the recall2
BASG reference number INS-640.001-0178

Further inquiry note